Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017, Article ID 8349150, 11 pages
https://doi.org/10.1155/2017/8349150
Review Article

Hepatitis C Virus and Nonliver Solid Cancers: Is There an Association between HCV and Cancers of the Pancreas, Thyroid, Kidney, Oral Cavity, Breast, Lung, and Gastrointestinal Tract?

1New York Medical College and Westchester Medical Center, 100 Woods Road, Valhalla, NY 10595, USA
2Bristol-Myers Squibb, 5 Research Pkwy, Wallingford, CT 06492, USA

Correspondence should be addressed to Saad Qadwai; moc.liamtoh@iawdaq_s

Received 30 December 2016; Revised 28 March 2017; Accepted 3 April 2017; Published 3 May 2017

Academic Editor: Haruhiko Sugimura

Copyright © 2017 Saad Qadwai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Gower, C. Estes, S. Blach, K. Razavi-Shearer, and H. Razavi, “Global epidemiology and genotype distribution of the hepatitis C virus infection,” Journal of Hepatology, vol. 61, Supplement 1, no. 1, pp. S45–S57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. M. Denniston, R. B. Jiles, J. Drobeniuc et al., “Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010,” Annals of Internal Medicine, vol. 160, no. 5, pp. 293–300, 2014. View at Publisher · View at Google Scholar
  3. Z. M. Younossi, F. Kanwal, S. Saab et al., “The impact of hepatitis C burden: an evidence-based approach,” Alimentary Pharmacology & Therapeutics, vol. 39, no. 5, pp. 518–531, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. T. P. Giordano, L. Henderson, O. Landgren et al., “Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus,” Journal of the American Medical Association, vol. 297, no. 18, pp. 2010–2017, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. H. M. Ko, J. C. Hernandez-Prera, H. Zhu et al., “Morphologic features of extrahepatic manifestations of hepatitis C virus infection,” Clinical & Developmental Immunology, vol. 2012, Article ID 740138, p. 9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Sansonno, G. Lauletta, M. Montrone, G. Grandaliano, F. P. Schena, and F. Dammacco, “Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection,” Clinical and Experimental Immunology, vol. 140, no. 3, pp. 498–506, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Carrozzo, R. Quadri, P. Latorre et al., “Molecular evidence that the hepatitis C virus replicates in the oral mucosa,” Journal of Hepatology, vol. 37, no. 3, pp. 364–369, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. F. V. Chisari, “Cytotoxics T cell and viral hepatitis,” The Journal of Clinical Investigation, vol. 99, no. 7, pp. 1472–1477, 1997. View at Publisher · View at Google Scholar
  9. J. Lamontagne, M. Pinkerton, T. M. Block, and X. Lu, “Hepatitis B and hepatitis C virus replication upregulates serine protease inhibitor Kazal, resulting in cellular resistance to serine-protease dependent apoptosis,” Journal of Virolog, vol. 84, no. 2, pp. 907–917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Lukkonen, S. Lintula, K. von Boguslawski et al., “Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients,” International Journal of Cancer, vol. 83, no. 4, pp. 486–490, 1999. View at Publisher · View at Google Scholar
  11. K. Machida, K. T. Cheng, V. M. Sung et al., “Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 12, pp. 4262–4267, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Okayasu, M. Fujiwara, Y. Hara, Y. Tanaka, and N. R. Rose, “Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans,” Cancer, vol. 76, no. 11, pp. 2312–2318, 1995. View at Publisher · View at Google Scholar
  13. Y. Katakura, H. Yotsuyanagi, K. Hashizume et al., “Pancreatic involvement in chronic viral hepatitis,” World Journal of Gastroenterology, vol. 11, no. 23, pp. 3508–3513, 2005. View at Publisher · View at Google Scholar
  14. D. Taranto, A. Carrato, M. Romano, G. Maio, C. M. Izzo, and C. Del Vecchio Blanco, “Mild pancreatic damage in acute viral heptitis,” Digestion, vol. 42, no. 2, pp. 93–97, 1989. View at Google Scholar
  15. S. Raza, N. A. Chaudhry, J. D. Brown et al., “To study the clinical, biochemical and radiological features of acute pancreatitis in HIV and AIDS,” Journal of Clinical Medicine Research, vol. 5, no. 1, pp. 12–17, 2013. View at Publisher · View at Google Scholar
  16. S. C. Gumber and S. Chopra, “Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations,” Annals of Internal Medicine, vol. 123, no. 8, pp. 615–620, 1995. View at Publisher · View at Google Scholar
  17. S. Silverman Jr, “Oral lichen planus: a potentially premalignant lesion,” Journal of Oral and Maxillofacial Surgery, vol. 58, no. 11, pp. 1286–1288, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Malaguarnera, G. Pistone, S. Neri, M. Romano, A. Brogna, and S. Musumeci, “Interleukin-2 plus ribavirin versus interferon-alpha-2b plus ribavirin in patients with chronic hepatitis C who did not respond to previous interferon-alpha-2b treatment,” BioDrugs, vol. 18, no. 6, pp. 407–413, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Malaguarnera, N. Guccione, S. Musumeci, A. Brogna, M. Motta, and I. Di Fazio, “Intravenous immunoglobulin plus interferon-alpha in autoimmune hepatitis C,” BioDrugs, vol. 18, no. 1, pp. 63–70, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Battegay, “Immunity to hepatitis C virus: a further piece of the puzzle,” Hepatology, vol. 24, no. 4, pp. 961–963, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Malaguarnera, L. Ferlito, S. Di Mauro, R. M. Imbesi, G. Scalia, and M. Malaguarnera, “Immunosenescence and cancer: a review,” Archives of Gerontology and Geriatrics, vol. 32, no. 2, pp. 77–93, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. S. M. Woo, J. Joo, W. J. Lee et al., “Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study,” Journal of Korean Medical Science, vol. 28, no. 2, pp. 247–251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. C. Chang, C. H. Chen, J. D. Liang et al., “Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma,” World Journal of Gastroenterology, vol. 20, no. 17, pp. 5060–5065, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. M. Hassan, D. Li, A. S. El-Deeb et al., “Association between hepatitis B virus and pancreatic cancer,” Journal of Clinical Oncology, vol. 26, no. 28, pp. 4557–4562, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. S. K. Abe, M. Inoue, N. Sawada et al., “Hepatitis B and C virus infection and risk of pancreatic cancer: a population-based cohort study (JPHC study cohort II),” Cancer Epidemiology, Biomarkers & Prevention, vol. 25, no. 3, pp. 555–557, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Huang, M. Magnusson, A. Törner, W. Ye, and A. S. Duberg, “Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden,” British Journal of Cancer, vol. 109, no. 11, pp. 2917–2923, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. H. B. El-Serag, E. A. Engels, O. Landgren et al., “Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of US veterans,” Hepatology, vol. 49, no. 1, pp. 116–123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Amin, G. J. Dore, D. L. O’Connell et al., “Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study,” Journal of Hepatology, vol. 45, no. 2, pp. 197–203, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Antonelli, C. Ferri, P. Fallahi et al., “Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study,” Thyroid, vol. 17, no. 5, pp. 447–451, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Montella, L. Pezzullo, A. Crispo et al., “Risk of thyroid cancer and high prevalence of hepatitis C virus,” Oncology Reports, vol. 10, no. 1, pp. 133–136, 2003. View at Google Scholar
  31. A. Antonelli, C. Ferri, P. Fallahi, C. Nesti, A. L. Zignego, and M. Maccheroni, “Thyroid cancer in HCV-related mixed cryoglobulinemia patients,” Clinical and Experimental Rheumatology, vol. 20, no. 5, pp. 693–696, 2002. View at Google Scholar
  32. M. Montella, A. Crispo, G. de Bellis et al., “HCV and cancer: a case-control study in a high-endemic area,” Liver, vol. 21, no. 5, pp. 335–341, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Antonelli, C. Ferri, and P. Fallahi, “Thyroid cancer in patients with hepatitis C infection,” Journal of the American Medical Association, vol. 281, no. 17, p. 1588, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. R. D. Allison, X. Tong, A. C. Moorman et al., “Chronic Hepatitis Cohort Study (CHeCS) investigators. Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010,” Journal of Hepatology, vol. 63, no. 4, pp. 822–828, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. L. H. Omland, D. K. Farkas, P. Jepsen, N. Obel, and L. Pedersen, “Hepatitis C virus infection and risk of cancer: a population-based cohort study,” Clinical Epidemiology, vol. 2, no. 2, pp. 179–186, 2010. View at Google Scholar
  36. A. Swart, L. Burns, L. Mao et al., “The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort study,” BMJ Open, vol. 2, no. 5, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. S. Duberg, M. Nordström, A. Törner et al., “Non-Hodgkin’s lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection,” Hepatology, vol. 41, no. 3, pp. 652–659, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. H. C. Gonzalez, L. Lamerato, C. G. Rogers, and S. C. Gordon, “Chronic hepatitis C infection as a risk factor for renal cell carcinoma,” Digestive Diseases and Sciences, vol. 60, no. 6, pp. 1820–1824, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Malaguarnera, M. P. Gargante, C. Risino et al., “Hepatitis C virus in elderly cancer patients,” European Journal of Internal Medicine, vol. 17, no. 5, pp. 325–329, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Budakoğlu, S. Aksoy, Ç. Arslan et al., “Frequency of HCV infection in renal cell carcinoma patients,” Medical Oncology, vol. 29, no. 3, pp. 1892–1895, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. S. C. Gordon, D. Moonka, K. A. Brown et al., “Risk for renal cell carcinoma in chronic hepatitis C infection,” Cancer Epidemiology, Biomarkers & Prevention, vol. 19, no. 4, pp. 1066–1073, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. J. N. Hofmann, A. Törner, W. H. Chow, W. Ye, M. P. Purdue, and A. S. Duberg, “Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden,” European Journal of Cancer Prevention, vol. 20, no. 4, pp. 326–330, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Nagao, M. Sata, K. Itoh et al., “High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma,” Hepatology Research, vol. 7, no. 3, pp. 206–212, 1997. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Takata, T. Takahashi, and J. Fukuda, “Prevalence of hepatitis virus infection in association with oral diseases requiring surgery,” Oral Diseases, vol. 8, no. 2, pp. 95–99, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. F. H. Su, S. N. Chang, P. C. Chen et al., “Positive association between hepatitis C infection and oral cavity cancer: a nationwide population-based cohort study in Taiwan,” PloS One, vol. 7, no. 10, article e48109, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. F. H. Su, S. N. Chang, P. C. Chen, F. C. Sung, C. T. Su, and C. C. Yeh, “Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study,” BMC Cancer, vol. 11, no. 1, p. 495, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Larrey, M. C. Bozonnat, I. Kain, G. P. Pageaux, and E. Assenat, “Is chronic hepatitis C virus infection a risk factor for breast cancer?” World Journal of Gastroenterology, vol. 16, no. 29, pp. 3687–3691, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Uzun, S. Alıcı, B. Ozbay, M. Gencer, and H. Irmak, “The incidence of hepatitis C virus in patients with lung cancer,” The Turkish Respiratory Journal, vol. 3, pp. 91–93, 2002. View at Google Scholar
  49. K. S. Zaret, “Genetic programming of liver and pancreas progenitors: lessons for stem-cell differentiation,” Nature Reviews. Genetics, vol. 9, no. 5, pp. 329–340, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Wandzioch and K. S. Zaret, “Dynamic signaling network for the specification of embryonic pancreas and liver progenitors,” Science, vol. 324, no. 5935, pp. 1707–1710, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Wiwanitkit, “Renal cell carcinoma and hepatitis C virus infection: is there any cause-outcome relationship?” Journal of Cancer Research and Therapeutics, vol. 7, no. 2, pp. 226–227, 2011. View at Publisher · View at Google Scholar · View at Scopus